title: The effect of 12 months' treatment with eicosapentaenoic acid in five children with cystic fibrosis.
abstract: Five children with cystic fibrosis (CF) and chronic suppurative lung disease had eicosapentaenoic acid (EPA) supplementation for 12 months. Outcome was measured by the change in frequency of admissions/bed days while taking EPA compared to the previous 2 years. Although no significant changes occurred, there is an indication that this treatment may benefit children who don't have end-stage disease. Further studies are indicated in the use of this neglected mode of treatment.
authors.affiliation: Warrnambool Base Hospital, Victoria, Australia.
authors.forename: N H
authors.initials: NH
authors.lastname: Thies
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004334:Drug Administration Schedule; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D011379:Prognosis; D012129:Respiratory Function Tests; D016896:Treatment Outcome
chemical_list: D015118:Eicosapentaenoic Acid